Why can't generic drugs new to the market be regulated so that they reflect their real cost and value? Ie. Generic Aciphex came out a while back and was covered by insurance. It has recently gone up to $900 for a 3-month supply of a generic drug from various companies that had nothing to do with its research and development. Why is the Affordable Care Act not addressing this issue?
This is historical material “frozen in time”. The website is no longer updated and links to external websites and some internal pages may not work.
